Clinical Trial Update: A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 dose optimization study of enzalutamide in elderly patients with advanced prostate cancer is planned and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer Patients, Elderly Patients | Phase 2 | Status: NOT_YET_RECRUITING